SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-17-001742
Filing Date
2017-07-10
Accepted
2017-07-10 06:03:20
Documents
4
Period of Report
2017-07-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm 8-K 23255
2 DIRECTOR OFFER LETTER pharmacyte_ex1001.htm EX-10.1 29474
3 GRAPHIC image_001.jpg GRAPHIC 5459
4 PRESS RELEASE pharmacyte_ex9901.htm EX-99.1 14330
  Complete submission text file 0001683168-17-001742.txt   76201
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 17956268
SIC: 2833 Medicinal Chemicals & Botanical Products